Effect of Moxidectin Treatment at Peripartum on Gastrointestinal Parasite Infections in Ewes Raised under Tropical Andes High Altitude Conditions

Table 2

Treatment-induced differences in the median of ratio change of clinical (FAMACHA© and Dag score) and zootechnical (body weight and body condition) parameters.

Measured parameters	Median (min–max)
	Untreated control group	Late pregnancy Mox injection	48 hours postlambing Mox injection
Change ratio
FAMACHA	0.73 (0.5–1)^a	1 (0.67–1.25)^b	0.67 (0.67–1)^a
Dag score	1.75 (0.5–2)^a	1 (0.67–3)^b	1.16 (0.67–2)^ab
Body weight	1.19 (1.06–1.28)	1.16 (1.02–1.4)	1.19 (1.05–1.42)
Body condition	1.04 (0.82–1.03)	1 (0.7–1.2)	1 (0.67–1.3)

Data were calculated by dividing the median of the parameter values before treatment (dry, mating, midpregnancy, and late pregnancy) over its median after treatment (early, intermediate, late, and preweaning period). Min: minimum value; max: maximum value; FAMACHA© values (1–5); Dag score values (0–5); body condition values (1–5). Three C ewes with high FEC and associated clinical signs were excluded after intermediate postpartum period due to Mox treatment. Significant differences between treatments (one-way ANOVA, ). Treatment differences (Tukey test, ) are denoted by superscripts.